Atlantic American Corp 10-Q for FY2021 Q1
Atlantic American Corp (AAME)
10-Q
2021-05-11
For: 2021-03-31
View Original
Added on
April 09, 2026
About this 10-Q
Atlantic American Corp filed this 10-Q on May 11, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $49.08M
- up 24.5% from $39.41M a year earlier
- Net loss
- $431K
- compared with a net loss of $8.09M a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| ☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended March 31, 2021
or
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number 0-3722
ATLANTIC AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)
|
Georgia
|
58-1027114
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
4370 Peachtree Road, N.E.,
Atlanta, Georgia
|
30319
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(404) 266-5500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
Common Stock, par value $1.00 per share
|
AAME
|
NASDAQ Global Market
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large
accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☑ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
The total number of shares of the registrant’s Common Stock, $1 par value, outstanding on April 30, 2021 was 20,415,782.
ATLANTIC AMERICAN CORPORATION
TABLE OF CONTENTS
|
Part I.
|
Financial Information
|
|
|
Item 1.
|
2
|
|
|
2
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
7
|
||
|
Item 2.
|
16 | |
|
Item 4.
|
21
|
|
|
Part II.
|
Other Information
|
|
|
Item 2.
|
22
|
|
|
Item 6.
|
22
|
|
| 23 |
Item 1. Financial Statements
ATLANTIC AMERICAN CORPORATION
(Dollars in thousands, except share data)
|
Unaudited
March 31,
2021
|
December 31,
2020
|
|||||||
|
ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
20,446
|
$
|
19,319
|
||||
|
Investments:
|
||||||||
|
Fixed maturities, available-for-sale, at fair value (amortized cost: $229,024 and $222,461)
|
246,801
|
254,106
|
||||||
|
Equity securities, at fair value (cost: $4,833 and $6,393)
|
17,900
|
18,716
|
||||||
|
Other invested assets (cost: $3,765 and $3,765)
|
3,183
|
3,238
|
||||||
|
Policy loans
|
1,963
|
1,975
|
||||||
|
Real estate
|
38
|
38
|
||||||
|
Investment in unconsolidated trusts
|
1,238
|
1,238
|
||||||
|
Total investments
|
271,123
|
279,311
|
||||||
|
Receivables:
|
||||||||
|
Reinsurance
|
29,511
|
29,086
|
||||||
|
Insurance premiums and other (net of allowance for doubtful accounts: $185 and $198)
|
9,850
|
27,512
|
||||||
|
Deferred income taxes, net
|
2,103
|
—
|
||||||
|
Deferred acquisition costs
|
38,098
|
39,611
|
||||||
|
Other assets
|
9,452
|
7,804
|
||||||
|
Intangibles
|
2,544
|
2,544
|
||||||
|
Total assets
|
$
|
383,127
|
$
|
405,187
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Insurance reserves and policyholder funds:
|
||||||||
|
Future policy benefits
|
$
|
89,017
|
$
|
90,872
|
||||
|
Unearned premiums
|
20,505
|
27,131
|
||||||
|
Losses and claims
|
81,285
|
79,147
|
||||||
|
Other policy liabilities
|
1,176
|
1,526
|
||||||
|
Total insurance reserves and policyholder funds
|
191,983
|
198,676
|
||||||
|
Accounts payable and accrued expenses
|
24,171
|
26,412
|
||||||
|
Deferred income taxes, net
|
—
|
1,301
|
||||||
|
Junior subordinated debenture obligations, net
|
33,738
|
33,738
|
||||||
|
Total liabilities
|
249,892
|
260,127
|
||||||
|
Commitments and contingencies (Note 10)
|
||||||||
|
Shareholders’ equity:
|
||||||||
|
Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value
|
55
|
55
|
||||||
|
Common stock, $1 par, 50,000,000 shares authorized; shares issued: 22,400,894; shares outstanding: 20,415,782 and 20,415,243
|
22,401
|
22,401
|
||||||
|
Additional paid-in capital
|
57,438
|
57,437
|
||||||
|
Retained earnings
|
46,852
|
47,790
|
||||||
|
Accumulated other comprehensive income
|
14,044
|
25,000
|
||||||
|
Unearned stock grant compensation
|
(217
|
)
|
(284
|
)
|
||||
|
Treasury stock, at cost: 1,985,112 and 1,985,651 shares
|
(7,338
|
)
|
(7,339
|
)
|
||||
|
Total shareholders’ equity
|
133,235
|
145,060
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
383,127
|
$
|
405,187
|
||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands, except per share data)
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Revenue:
|
||||||||
|
Insurance premiums, net
|
$
|
46,090
|
$
|
45,550
|
||||
|
Net investment income
|
2,113
|
2,039
|
||||||
|
Realized investment gains, net
|
121
|
249
|
||||||
|
Unrealized gains (losses) on equity securities, net
|
744
|
(8,455
|
)
|
|||||
|
Other income
|
7
|
27
|
||||||
|
Total revenue
|
49,075
|
39,410
|
||||||
|
Benefits and expenses:
|
||||||||
|
Insurance benefits and losses incurred
|
33,272
|
33,583
|
||||||
|
Commissions and underwriting expenses
|
12,564
|
12,626
|
||||||
|
Interest expense
|
346
|
476
|
||||||
|
Other expense
|
3,440
|
2,952
|
||||||
|
Total benefits and expenses
|
49,622
|
49,637
|
||||||
|
Loss before income taxes
|
(547
|
)
|
(10,227
|
)
|
||||
|
Income tax benefit
|
(116
|
)
|
(2,140
|
)
|
||||
|
Net loss
|
(431
|
)
|
(8,087
|
)
|
||||
|
Preferred stock dividends
|
(99
|
)
|
(99
|
)
|
||||
|
Net loss applicable to common shareholders
|
$
|
(530
|
)
|
$
|
(8,186
|
)
|
||
|
Loss per common share (basic and diluted)
|
$
|
(.03
|
)
|
$
|
(.40
|
)
|
||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands)
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Net loss
|
$
|
(431
|
)
|
$
|
(8,087
|
)
|
||
|
Other comprehensive loss:
|
||||||||
|
Available-for-sale fixed maturity securities:
|
||||||||
|
Gross unrealized holding loss arising in the period
|
(13,747
|
)
|
(10,880
|
)
|
||||
|
Related income tax effect
|
2,887
|
2,285
|
||||||
|
Subtotal
|
(10,860
|
)
|
(8,595
|
)
|
||||
|
Less: reclassification adjustment for net realized gains included in net loss
|
(121
|
)
|
(249
|
)
|
||||
|
Related income tax effect
|
25
|
52
|
||||||
|
Subtotal
|
(96
|
)
|
(197
|
)
|
||||
|
Total other comprehensive loss, net of tax
|
(10,956
|
)
|
(8,792
|
)
|
||||
|
Total comprehensive loss
|
$
|
(11,387
|
)
|
$
|
(16,879
|
)
|
||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands except share data)
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Preferred stock:
|
||||||||
|
Balance, beginning of period
|
$
|
55
|
$
|
55
|
||||
|
Balance, end of period
|
55
|
55
|
||||||
|
Common stock:
|
||||||||
|
Balance, beginning of period
|
22,401
|
22,401
|
||||||
|
Balance, end of period
|
22,401
|
22,401
|
||||||
|
Additional paid-in capital:
|
||||||||
|
Balance, beginning of period
|
57,437
|
57,820
|
||||||
|
Restricted stock grants, net of forfeitures
|
—
|
(44
|
)
|
|||||
|
Issuance of 539 and 1,204 shares, as of 2021 and 2020, respectively, under stock plans
|
1
|
1
|
||||||
|
Balance, end of period
|
57,438
|
57,777
|
||||||
|
Retained earnings:
|
||||||||
|
Balance, beginning of period
|
47,790
|
36,020
|
||||||
|
Net loss
|
(431
|
)
|
(8,087
|
)
|
||||
|
Dividends on common stock
|
(408
|
)
|
—
|
|||||
|
Dividends accrued on preferred stock
|
(99
|
)
|
(99
|
)
|
||||
|
Balance, end of period
|
46,852
|
27,834
|
||||||
|
Accumulated other comprehensive income (loss):
|
||||||||
|
Balance, beginning of period
|
25,000
|
10,459
|
||||||
|
Other comprehensive loss, net of tax
|
(10,956
|
)
|
(8,792
|
)
|
||||
|
Balance, end of period
|
14,044
|
1,667
|
||||||
|
Unearned Stock Grant Compensation:
|
||||||||
|
Balance, beginning of period
|
(284
|
)
|
(781
|
)
|
||||
|
Restricted stock grants, net of forfeitures
|
—
|
98
|
||||||
|
Amortization of unearned compensation
|
67
|
99
|
||||||
|
Balance, end of period
|
(217
|
)
|
(584
|
)
|
||||
|
Treasury Stock:
|
||||||||
|
Balance, beginning of period
|
(7,339
|
)
|
(7,580
|
)
|
||||
|
Restricted stock grants, net of forfeitures
|
—
|
(54
|
)
|
|||||
|
Issuance of 539 and 1,204 shares, as of 2021 and 2020, respectively, under stock plans
|
1
|
2
|
||||||
|
Balance, end of period
|
(7,338
|
)
|
(7,632
|
)
|
||||
|
Total shareholders’ equity
|
$
|
133,235
|
$
|
101,518
|
||||
|
Dividends declared on common stock per share
|
$
|
0.02
|
$
|
—
|
||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands)
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net loss
|
$
|
(431
|
)
|
$
|
(8,087
|
)
|
||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Amortization of acquisition costs, net
|
1,513
|
556
|
||||||
|
Realized investment gains, net
|
(121
|
)
|
(249
|
)
|
||||
|
Unrealized (gains) losses on equity securities, net
|
(744
|
)
|
8,455
|
|||||
|
Compensation expense related to share awards
|
67
|
99
|
||||||
|
Depreciation and amortization
|
264
|
251
|
||||||
|
Deferred income tax benefit
|
(492
|
)
|
(2,269
|
)
|
||||
|
Decrease in receivables, net
|
4,559 |
3,218
|
||||||
|
Decrease in insurance reserves and policyholder funds
|
(6,693
|
)
|
(9,060
|
)
|
||||
|
Decrease in accounts payable and accrued expenses
|
(2,250
|
)
|
(3,928
|
)
|
||||
|
Other, net
|
(1,716
|
)
|
502
|
|||||
|
Net cash used in operating activities
|
(6,044
|
) |
(10,512
|
)
|
||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Proceeds from investments sold
|
13,266
|
5,641
|
||||||
|
Proceeds from investments matured, called or redeemed
|
4,506
|
2,555
|
||||||
|
Investments purchased
|
(10,564
|
)
|
(2,204
|
)
|
||||
|
Additions to property and equipment
|
(39
|
)
|
(38
|
)
|
||||
|
Net cash provided by investing activities
|
7,169
|
|
5,954
|
|||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Proceeds from shares issued under stock plans
|
2
|
3
|
||||||
|
Net cash provided by financing activities
|
2
|
3
|
||||||
|
Net increase (decrease) in cash and cash equivalents
|
1,127
|
(4,555
|
)
|
|||||
|
Cash and cash equivalents at beginning of period
|
19,319
|
12,893
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
20,446
|
$
|
8,338
|
||||
|
SUPPLEMENTAL CASH FLOW INFORMATION:
|
||||||||
|
Cash paid for interest
|
$
|
351
|
$
|
491
|
||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands, except per share amounts)
| Note 1. |
Basis of Presentation
|
The accompanying unaudited condensed consolidated financial statements include the accounts of Atlantic American Corporation (the “Parent”) and its subsidiaries (collectively with the Parent, the
“Company”). The Parent’s primary operating subsidiaries, American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance
Company (together known as “Bankers Fidelity”), operate in two principal business units. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. All
significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for audited annual financial statements. In the opinion of
management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The unaudited condensed consolidated financial statements included herein and these related notes should
be read in conjunction with the Company’s consolidated financial statements, and the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”). The Company’s financial
condition and results of operations and cash flows as of and for the three month period ended March 31, 2021 are not necessarily indicative of the financial condition or results of operations and cash flows that may be expected for the year ending
December 31, 2021 or for any other future period.
The Company’s significant accounting policies have not changed materially from those set out in the 2020 Annual Report, except as noted below for the adoption of new accounting standards.
The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosures of
contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.
On March 11, 2020, the World Health Organization declared the Novel Coronavirus (“COVID-19”) outbreak a global pandemic. The impact of COVID-19 and related actions to attempt to control its spread
began to impact the Company’s business operations in March 2020, and we expect that the pandemic, actions that have been or will be taken in response to it and its overall impact on the economy, will continue to have an effect on our business
operations and our operating results. The Company’s insurance subsidiaries may experience difficulties collecting premiums from some policyholders, and policyholders with financial difficulties may decide not to renew insurance policies with the
Company. Although the ultimate impact cannot be predicted with certainty at this time, the Company’s insurance subsidiaries do not expect a direct material impact from the outbreak of COVID-19 in terms of increased claims and losses, but that may
change as more information becomes available. In addition, economic uncertainty related to COVID-19 has led to, and may continue to create, increased volatility in the investment markets. The impact of COVID-19 on the economy and on the Company
continues to evolve and its future effects are uncertain. The Company continues to monitor the effects and risks of COVID-19 to assess its impact on the Company’s business, financial condition, results of operations, liquidity and capital position.
| Note 2. |
Recently Issued Accounting Standards
|
Adoption of New Accounting Standards
Income Taxes – Simplifying the Accounting for Income Taxes. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes (“ASU 2019-12”). This updated guidance is intended to simplify the accounting for income taxes by removing several exceptions contained in existing guidance and amending other existing guidance to simplify several other income tax accounting
matters. The updated guidance is effective for interim and annual reporting periods beginning after December 15, 2020, although earlier adoption is permitted. The Company adopted ASU 2019-12 as of January 1, 2021. The adoption of this ASU did not
have an impact on the Company’s consolidated financial statements.
Future Adoption of New Accounting Standards
For more information regarding accounting standards that the Company has not yet adopted, see the “Recently Issued Accounting Standards - Future Adoption of New Accounting Standards” section of
Note 1 of Notes to Consolidated Financial Statements in the 2020 Annual Report.
| Note 3. |
Investments
|
The following tables set forth the estimated fair value, gross unrealized gains, gross unrealized losses and cost or amortized cost of the Company’s investments in fixed maturities and equity
securities, aggregated by type and industry, as of March 31, 2021 and December 31, 2020.
Fixed maturities were comprised of the following:
|
March 31, 2021
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
|
Fixed maturities:
|
||||||||||||||||
|
Bonds:
|
||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
34,639
|
$
|
788
|
$
|
260
|
$
|
34,111
|
||||||||
|
Obligations of states and political subdivisions
|
11,559
|
658
|
—
|
10,901
|
||||||||||||
|
Corporate securities:
|
||||||||||||||||
|
Utilities and telecom
|
29,295
|
2,505
|
137
|
26,927
|
||||||||||||
|
Financial services
|
74,847
|
6,254
|
271
|
68,864
|
||||||||||||
|
Other business – diversified
|
38,959
|
3,277
|
264
|
35,946
|
||||||||||||
|
Other consumer – diversified
|
57,252
|
5,348
|
179
|
52,083
|
||||||||||||
|
Total corporate securities
|
200,353
|
17,384
|
851
|
183,820
|
||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||
|
Other consumer – diversified
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total redeemable preferred stocks
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total fixed maturities
|
$
|
246,801
|
$
|
18,888
|
$
|
1,111
|
$
|
229,024
|
||||||||
|
December 31, 2020
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
|
Fixed maturities:
|
||||||||||||||||
|
Bonds:
|
||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
30,762
|
$
|
1,381
|
$
|
26
|
$
|
29,407
|
||||||||
|
Obligations of states and political subdivisions
|
11,802
|
898
|
—
|
10,904
|
||||||||||||
|
Corporate securities:
|
||||||||||||||||
|
Utilities and telecom
|
30,359
|
4,423
|
—
|
25,936
|
||||||||||||
|
Financial services
|
78,258
|
9,811
|
6
|
68,453
|
||||||||||||
|
Other business – diversified
|
41,145
|
5,689
|
15
|
35,471
|
||||||||||||
|
Other consumer – diversified
|
61,530
|
9,479
|
47
|
52,098
|
||||||||||||
|
Total corporate securities
|
211,292
|
29,402
|
68
|
181,958
|
||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||
|
Other consumer – diversified
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total redeemable preferred stocks
|
250
|
58
|
—
|
192
|
||||||||||||
|
Total fixed maturities
|
$
|
254,106
|
$
|
31,739
|
$
|
94
|
$
|
222,461
|
||||||||
Bonds having an amortized cost of $10,444 and $10,670 and included in the tables above were on deposit with insurance regulatory authorities as of March 31, 2021 and December 31, 2020, respectively, in accordance with
statutory requirements. Additionally, bonds having an amortized cost of $6,391 and $1,997 and included in the tables above were pledged as collateral to FHLB at March 31, 2021 and December 31, 2020, respectively.
Equity securities were comprised of the following:
|
March 31, 2021
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
$
|
624
|
$
|
424
|
$
|
—
|
$
|
200
|
||||||||
|
Other business – diversified
|
17,276
|
12,643
|
—
|
4,633
|
||||||||||||
|
Total equity securities
|
$
|
17,900
|
$
|
13,067
|
$
|
—
|
$
|
4,833
|
||||||||
|
December 31, 2020
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
$
|
2,111
|
351
|
—
|
1,760
|
|||||||||||
|
Other business – diversified
|
16,605
|
11,972
|
—
|
4,633
|
||||||||||||
|
Total equity securities
|
$
|
18,716
|
$
|
12,323
|
$
|
—
|
$
|
6,393
|
||||||||
The carrying value and amortized cost of the Company’s investments in fixed maturities at March 31, 2021 and December 31, 2020 by contractual maturity were as follows. Actual maturities may differ
from contractual maturities because issuers may call or prepay obligations with or without call or prepayment penalties.
|
March 31, 2021
|
December 31, 2020
|
|||||||||||||||
|
Carrying
Value
|
Amortized
Cost
|
Carrying
Value
|
Amortized
Cost
|
|||||||||||||
|
Due in one year or less
|
$
|
3,031
|
$
|
3,001
|
$
|
2,041
|
$
|
2,015
|
||||||||
|
Due after one year through five years
|
16,633
|
15,539
|
18,373
|
17,039
|
||||||||||||
|
Due after five years through ten years
|
86,651
|
80,529
|
89,892
|
79,993
|
||||||||||||
|
Due after ten years
|
116,883
|
106,365
|
124,609
|
104,527
|
||||||||||||
|
Asset backed securities
|
23,603
|
23,590
|
19,191
|
18,887
|
||||||||||||
|
Totals
|
$
|
246,801
|
$
|
229,024
|
$
|
254,106
|
$
|
222,461
|
||||||||
The following tables present the Company’s unrealized loss aging for securities by type and length of time the security was in a continuous unrealized loss position as of March 31, 2021 and
December 31, 2020.
|
March 31, 2021
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
12,883
|
$
|
260
|
$
|
—
|
$
|
—
|
$
|
12,883
|
$
|
260
|
||||||||||||
|
Corporate securities
|
19,095
|
851
|
—
|
—
|
19,095
|
851
|
||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
31,978
|
$
|
1,111
|
$
|
—
|
$
|
—
|
$
|
31,978
|
$
|
1,111
|
||||||||||||
|
December 31, 2020
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
7,045
|
$
|
26
|
$
|
—
|
$
|
—
|
$
|
7,045
|
$
|
26
|
||||||||||||
|
Corporate securities
|
4,602
|
68
|
—
|
—
|
4,602
|
68
|
||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
11,647
|
$
|
94
|
$
|
—
|
$
|
—
|
$
|
11,647
|
$
|
94
|
||||||||||||
The evaluation for an other than temporary impairment (“OTTI”) is a quantitative and qualitative process, which is subject to risks and uncertainties in the determination of whether declines in the
fair value of investments are other than temporary. Potential risks and uncertainties include, among other things, changes in general economic conditions, an issuer’s financial condition or near term recovery prospects and the effects of changes in
interest rates. In evaluating a potential impairment, the Company considers, among other factors, management’s intent and ability to hold the securities until price recovery, the nature of the investment and the expectation of prospects for the
issuer and its industry, the status of an issuer’s continued satisfaction of its obligations in accordance with their contractual terms, and management’s expectation as to the issuer’s ability and intent to continue to do so, as well as ratings
actions that may affect the issuer’s credit status.
There were no OTTI charges recorded during the three month periods ended March 31, 2021 and 2020.
As of March 31, 2021 and December 31, 2020, there were thirty-seven and twenty securities, respectively, in an unrealized loss position which primarily included certain of the Company’s investments
in fixed maturities within the utilities and telecom, financial services, other diversified business and other diversified consumer sectors. The increase in the number of securities in an unrealized loss position during the three month period ended
March 31, 2021, was primarily attributable to a decline in market values in certain of the Company’s fixed maturity securities as a result of a rising interest rate environment. The Company does not currently intend to sell nor does it expect to
be required to sell any of the securities in an unrealized loss position. Based upon the Company’s expected continuation of receipt of contractually required principal and interest payments and its intent and ability to retain the securities until
price recovery, as well as the Company’s evaluation of other relevant factors, including those described above, the Company has deemed these securities to be temporarily impaired as of March 31, 2021.
The following table is a summary of realized investment gains for the three month period ended March 31, 2021 and 2020.
|
Three Months Ended
March 31, 2021
|
||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
121
|
$
|
—
|
$
|
—
|
$
|
121
|
||||||||
|
Losses
|
—
|
—
|
—
|
—
|
||||||||||||
|
Realized investment gains, net
|
$
|
121
|
$
|
—
|
$
|
—
|
$
|
121
|
||||||||
|
Three Months Ended
March 31, 2020
|
||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
249
|
$
|
—
|
$
|
—
|
$
|
249
|
||||||||
|
Losses
|
—
|
—
|
—
|
—
|
||||||||||||
|
Realized investment gains, net
|
$
|
249
|
$
|
—
|
$
|
—
|
$
|
249
|
||||||||
The following table presents the portion of unrealized gains (losses) related to equity securities still held for the three month period ended March 31, 2021 and 2020.
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Net realized and unrealized gains (losses) recognized during the period on equity securities
|
$
|
744
|
$
|
(8,455
|
)
|
|||
|
Less: Net realized gains (losses) recognized during the period on equity securities sold during the period
|
—
|
—
|
||||||
|
Unrealized gains (losses) recognized during the reporting period on equity securities, net
|
$
|
744
|
$
|
(8,455
|
)
|
|||
Variable Interest Entities
The Company holds passive interests in a number of entities that are considered to be variable interest entities (“VIEs”) under GAAP guidance. The Company’s VIE interests principally consist of
interests in limited partnerships and limited liability companies formed for the purpose of achieving diversified equity returns. The Company’s VIE interests, carried as a part of other invested assets, totaled $3,183 and $3,238 as of March 31,
2021 and December 31, 2020, respectively. The Company’s VIE interests, carried as a part of investment in unconsolidated trusts, totaled $1,238 as of March 31, 2021 and December 31, 2020.
The Company does not have power over the activities that most significantly impact the economic performance of these VIEs and thus is not the primary beneficiary. Therefore, the Company has not
consolidated these VIEs. The Company’s involvement with each VIE is limited to its direct ownership interest in the VIE. The Company has no arrangements with any of the VIEs to provide other financial support to or on behalf of the VIE. The
Company’s maximum loss exposure relative to these investments was limited to the carrying value of the Company’s investment in the VIEs, which amount to $4,421 and $4,476, as of March 31, 2021 and December 31, 2020, respectively. As of March 31,
2021 and December 31, 2020, the Company had outstanding commitments totaling $1,997, whereby the Company is committed to fund these investments and may be called by the partnership during the commitment period to fund the purchase of new
investments and partnership expenses.
| Note 4. |
Fair Values of Financial Instruments
|
The estimated fair values have been determined by the Company using available market information from various market sources and appropriate valuation methodologies as of the respective dates.
However, considerable judgment is necessary to interpret market data and to develop the estimates of fair value. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, the estimates
presented herein are not necessarily indicative of the amounts which the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair
value amounts.
The following describes the fair value hierarchy and provides information as to the extent to which the Company uses fair value to measure the value of its financial instruments and information
about the inputs used to value those financial instruments. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad levels.
| Level 1 |
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1 criteria
include cash equivalents and exchange traded common stocks.
|
| Level 2 |
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly most of its
fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In
determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers.
Prices for the majority of the Company’s Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable
(e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.
|
| Level 3 |
Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily
observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the
asset or liability. The Company’s financial instruments valued using Level 3 criteria consist of two fixed maturity securities and one equity security. As of March 31, 2021 and December 31, 2020, the value of the fixed maturities valued
using Level 3 criteria was $250 and $0, respectively. As of March 31, 2021 and December 31, 2020, the value of the equity security valued using Level 3 criteria was $83 and $143, respectively. The equity security is not traded and valued
at cost. The use of different criteria or assumptions regarding data may have yielded materially different valuations.
|
As of March 31, 2021, financial instruments carried at fair value were measured on a recurring basis as summarized below:
|
Quoted Prices
in Active
Markets
for Identical
Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturities
|
$
|
—
|
$
|
246,551
|
$
|
250
|
$
|
246,801
|
||||||||
|
Equity securities
|
17,817
|
—
|
83
|
17,900
|
||||||||||||
|
Cash equivalents
|
9,011
|
—
|
—
|
9,011
|
||||||||||||
|
Total
|
$
|
26,828
|
$
|
246,551
|
$
|
333
|
$
|
273,712
|
||||||||
As of December 31, 2020, financial instruments carried at fair value were measured on a recurring basis as summarized below:
|
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturities
|
$
|
—
|
$
|
254,106
|
$
|
—
|
$
|
254,106
|
||||||||
|
Equity securities
|
18,573
|
—
|
143
|
18,716
|
||||||||||||
|
Cash equivalents
|
12,010
|
—
|
—
|
12,010
|
||||||||||||
|
Total
|
$
|
30,583
|
$
|
254,106
|
$
|
143
|
$
|
284,832
|
||||||||
The following table sets forth the carrying amount, estimated fair value and level within the fair value hierarchy of the Company’s financial instruments as of March 31, 2021 and December 31, 2020.
|
March 31, 2021
|
December 31, 2020
|
|||||||||||||||||||
|
Level in Fair
Value
Hierarchy (1)
|
Carrying
Amount
|
Estimated
Fair Value
|
Carrying
Amount
|
Estimated
Fair Value
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Cash and cash equivalents
|
Level 1
|
$
|
20,446
|
$
|
20,446
|
$
|
19,319
|
$
|
19,319
|
|||||||||||
|
Fixed maturities
|
(1)
|
|
246,801
|
246,801
|
254,106
|
254,106
|
||||||||||||||
|
Equity securities
|
(1)
|
17,900
|
17,900
|
18,716
|
18,716
|
|||||||||||||||
|
Other invested assets
|
Level 3
|
3,183
|
3,183
|
3,238
|
3,238
|
|||||||||||||||
|
Policy loans
|
Level 2
|
1,963
|
1,963
|
1,975
|
1,975
|
|||||||||||||||
|
Investment in unconsolidated trusts
|
Level 2
|
1,238
|
1,238
|
1,238
|
1,238
|
|||||||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Junior subordinated debentures, net
|
Level 2
|
33,738
|
34,021
|
33,738
|
32,297
|
|||||||||||||||
| (1) |
See the aforementioned information for a description of the fair value hierarchy as well as a disclosure of levels for classes of these financial assets.
|
| Note 5. |
Liabilities for Unpaid Losses, Claims and Loss Adjustment Expenses
|
The roll-forward of liabilities for unpaid losses, claims and loss adjustment expenses for the three months ended March 31, 2021 and 2020 is as follows:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
79,147
|
$
|
81,448
|
||||
|
Less: Reinsurance recoverable on unpaid losses
|
(17,600
|
)
|
(18,339
|
)
|
||||
|
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, net
|
61,547
|
63,109
|
||||||
|
Incurred related to:
|
||||||||
|
Current accident year
|
32,928
|
35,985
|
||||||
|
Prior accident year development (1)
|
475
|
(2)
|
(2,583
|
)(3)
|
||||
|
Total incurred
|
33,403
|
33,402
|
||||||
|
Paid related to:
|
||||||||
|
Current accident year
|
10,917
|
14,008
|
||||||
|
Prior accident years
|
20,984
|
20,856
|
||||||
|
Total paid
|
31,901
|
34,864
|
||||||
|
Ending liabilities for unpaid losses, claims and loss adjustment expenses, net
|
63,049
|
61,647
|
||||||
|
Plus: Reinsurance recoverable on unpaid losses
|
18,236
|
18,548
|
||||||
|
Ending liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
81,285
|
$
|
80,195
|
||||
| (1) |
In establishing property and casualty reserves, the Company initially reserves for losses at the higher end of the reasonable range if no other value within the range is determined to be more probable. Selection of such an initial loss
estimate is an attempt by management to give recognition that initial claims information received generally is not conclusive with respect to legal liability, is generally not comprehensive with respect to magnitude of loss and generally,
based on historical experience, will develop more adversely as time passes and more information becomes available. Accordingly, the Company generally experiences reserve redundancies when analyzing the development of prior year losses in a
current period.
|
| (2) |
Prior years’ development was primarily the result of unfavorable development in the loss and claim reserves for the Medicare supplement line of business in Bankers Fidelity. Partially offsetting the unfavorable development was favorable
development in the property and casualty operations.
|
| (3) |
Prior years’ development was primarily the result of favorable development in the loss and claim reserves for the Medicare supplement line of business in Bankers Fidelity. Rate increases on existing business and the resultant
improvement in rate adequacy was more favorable than expected.
|
Following is a reconciliation of total incurred losses to total insurance benefits and losses incurred:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Total incurred losses
|
$
|
33,403
|
$
|
33,402
|
||||
|
Cash surrender value and matured endowments
|
247
|
368
|
||||||
|
Benefit reserve changes
|
(378
|
)
|
(187
|
)
|
||||
|
Total insurance benefits and losses incurred
|
$
|
33,272
|
$
|
33,583
|
||||
| Note 6. |
Junior Subordinated Debentures
|
The Company has two unconsolidated Connecticut statutory business trusts, which exist for the exclusive purposes of: (i) issuing trust preferred securities (“Trust Preferred Securities”)
representing undivided beneficial interests in the assets of the trusts; (ii) investing the gross proceeds of the Trust Preferred Securities in junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) of Atlantic
American; and (iii) engaging in those activities necessary or incidental thereto.
The financial structure of each of Atlantic American Statutory Trust I and II as of March 31, 2021 was as follows:
|
Atlantic American
Statutory Trust I
|
Atlantic American
Statutory Trust II
|
|||||||
|
JUNIOR SUBORDINATED DEBENTURES (1) (2)
|
||||||||
|
Principal amount owed March 31, 2021
|
$
|
18,042
|
$
|
23,196
|
||||
|
Less: Treasury debt (3)
|
—
|
(7,500
|
)
|
|||||
|
Net balance March 31, 2021
|
$
|
18,042
|
$
|
15,696
|
||||
|
Net balance December 31, 2020
|
$
|
18,042
|
$
|
15,696
|
||||
|
Coupon rate
|
LIBOR + 4.00%
|
LIBOR + 4.10%
|
||||||
|
Interest payable
|
Quarterly
|
Quarterly
|
||||||
|
Maturity date
|
December 4, 2032
|
May 15, 2033
|
||||||
|
Redeemable by issuer
|
Yes
|
Yes
|
||||||
|
TRUST PREFERRED SECURITIES
|
||||||||
|
Issuance date
|
December 4, 2002
|
May 15, 2003
|
||||||
|
Securities issued
|
17,500
|
22,500
|
||||||
|
Liquidation preference per security
|
$
|
1
|
$
|
1
|
||||
|
Liquidation value
|
$
|
17,500
|
$
|
22,500
|
||||
|
Coupon rate
|
LIBOR + 4.00%
|
LIBOR + 4.10%
|
||||||
|
Distribution payable
|
Quarterly
|
Quarterly
|
||||||
|
Distribution guaranteed by (4)
|
Atlantic American
Corporation
|
Atlantic American
Corporation
|
||||||
| (1) |
For each of the respective debentures, the Company has the right at any time, and from time to time, to defer payments of interest on the Junior Subordinated Debentures for a period not exceeding 20 consecutive quarters up to the
debentures’ respective maturity dates. During any such period, interest will continue to accrue and the Company may not declare or pay any cash dividends or distributions on, or purchase, the Company’s common stock nor make any principal,
interest or premium payments on or repurchase any debt securities that rank equally with or junior to the Junior Subordinated Debentures. The Company has the right at any time to dissolve each of the trusts and cause the Junior Subordinated
Debentures to be distributed to the holders of the Trust Preferred Securities.
|
| (2) |
The Junior Subordinated Debentures are unsecured and rank junior and subordinate in right of payment to all senior debt of the Parent and are effectively subordinated to all existing and future liabilities of its subsidiaries.
|
| (3) |
On August 4, 2014, the Company acquired $7,500 of the Junior Subordinated Debentures.
|
| (4) |
The Parent has guaranteed, on a subordinated basis, all of the obligations under the Trust Preferred Securities, including payment of the redemption price and any accumulated and unpaid distributions to the extent of available funds and
upon dissolution, winding up or liquidation.
|
| Note 7. |
Loss Per Common Share
|
A reconciliation of the numerator and denominator used in the loss per common share calculations is as follows:
|
Three Months Ended
March 31, 2021
|
||||||||||||
|
Loss
|
Weighted
Average
Shares
(In thousands)
|
Per Share
Amount
|
||||||||||
|
Basic and Diluted Loss Per Common Share:
|
||||||||||||
|
Net loss
|
$
|
(431
|
)
|
20,415
|
|
|||||||
|
Less preferred stock dividends
|
(99
|
)
|
—
|
|||||||||
|
Net loss applicable to common shareholders
|
$
|
(530
|
)
|
20,415
|
$
|
(.03
|
)
|
|||||
|
Three Months Ended
March 31, 2020
|
||||||||||||
|
|
Loss
|
Weighted
Average
Shares
(In thousands)
|
Per Share
Amount
|
|||||||||
|
Basic and Diluted Loss Per Common Share:
|
||||||||||||
|
Net loss
|
$
|
(8,087
|
)
|
20,470
|
||||||||
|
Less preferred stock dividends
|
(99
|
)
|
—
|
|||||||||
|
Net loss applicable to common shareholders
|
$
|
(8,186
|
)
|
20,470
|
$
|
(.40
|
)
|
|||||
The assumed conversion of the Company’s Series D preferred stock was excluded from the loss per common share calculation for all periods presented since its impact would have been antidilutive.
| Note 8. |
Income Taxes
|
A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and income tax benefit is as follows:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Federal income tax provision at statutory rate of 21%
|
$
|
(115
|
)
|
$
|
(2,148
|
)
|
||
|
Dividends-received deduction
|
(9
|
)
|
(3
|
)
|
||||
|
Other permanent differences
|
8
|
11
|
||||||
|
Income tax benefit
|
$
|
(116
|
)
|
$
|
(2,140
|
)
|
||
The components of income tax benefit were:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Current – Federal
|
$
|
376
|
$
|
129
|
||||
|
Deferred – Federal
|
(492
|
)
|
(2,269
|
)
|
||||
|
Total
|
$
|
(116
|
)
|
$
|
(2,140
|
)
|
||
In addition, the Company determined there were no significant tax implications as a result of the CARES Act.
| Note 9. |
Leases
|
The Company has two operating lease agreements, each for the use of office space in the ordinary course of business. The first lease renews annually on an automatic basis and based on original
assumptions, management is reasonably certain to exercise the renewal option through 2026. The original term of the second lease was ten years and amended in January 2017 to provide for an additional seven years, with a termination date on
September 30, 2026. The rate used in determining the present value of lease payments is based upon an estimate of the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease.
These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Lease expense reported for the three months ended March
31, 2021 and March 31, 2020 was $254.
Additional information regarding the Company’s real estate operating leases is as follows:
|
Three Months Ended
March 31,
|
||||||||
|
Other information on operating leases:
|
2021
|
2020
|
||||||
|
Cash payments included in the measurement of lease liabilities reported in operating cash flows
|
$
|
251
|
$
|
978
|
||||
|
Right-of-use assets included in other assets on the condensed consolidated balance sheet
|
4,664
|
5,319
|
||||||
|
Weighted average discount rate
|
6.8
|
%
|
6.8
|
%
|
||||
|
Weighted average remaining lease term in years
|
5.6 years
|
6.6 years
|
||||||
The following table presents maturities and present value of the Company’s lease liabilities:
|
Lease Liability
|
||||
|
Remainder of 2021
|
$
|
764
|
||
|
2022
|
1,031
|
|||
|
2023
|
1,048
|
|||
|
2024
|
1,065
|
|||
|
2025
|
1,083
|
|||
|
Thereafter
|
942
|
|||
|
Total undiscounted lease payments
|
5,933
|
|||
|
Less: present value adjustment
|
1,031
|
|||
|
Operating lease liability included in accounts payable and accrued expenses on the condensed consolidated balance sheet
|
$
|
4,902
|
||
As of March 31, 2021, the Company has no operating leases that have not yet commenced.
| Note 10. |
Commitments and Contingencies
|
From time to time, the Company is, and expects to continue to be, involved in various claims and lawsuits incidental to and in the ordinary course of its businesses. In the opinion of management,
any such known claims are not expected to have a material effect on the financial condition or results of operations of the Company.
| Note 11. |
Segment Information
|
The Parent’s primary insurance subsidiaries, American Southern and Bankers Fidelity, operate in two principal business units, each focusing on specific products. American Southern operates in the
property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each business unit is managed independently and is evaluated on its individual performance. The following sets forth the assets,
revenue and loss before income taxes for each business unit as of and for the periods ended 2021 and 2020.
|
Assets
|
March 31,
2021
|
December 31,
2020
|
||||||
|
American Southern
|
$
|
145,081
|
$
|
158,808
|
||||
|
Bankers Fidelity
|
224,844
|
236,197
|
||||||
|
Corporate and Other
|
13,202
|
10,182
|
||||||
|
Total assets
|
$
|
383,127
|
$
|
405,187
|
||||
|
Three Months Ended
March 31,
|
||||||||
| Revenues |
2021
|
2020
|
||||||
|
American Southern
|
$
|
17,526
|
$
|
15,227
|
||||
|
Bankers Fidelity
|
31,540
|
24,873
|
||||||
|
Corporate and Other
|
9
|
(690
|
)
|
|||||
|
Total revenue
|
$
|
49,075
|
$
|
39,410
|
||||
|
Three Months Ended
March 31,
|
||||||||
|
Loss Before Income Taxes
|
2021
|
2020
|
||||||
|
American Southern
|
$
|
1,490
|
$
|
878
|
||||
|
Bankers Fidelity
|
134
|
(8,781
|
)
|
|||||
|
Corporate and Other
|
(2,171
|
)
|
(2,324
|
)
|
||||
|
Loss before income taxes
|
$
|
(547
|
)
|
$
|
(10,227
|
)
|
||
AND RESULTS OF OPERATIONS
The following is management’s discussion and analysis of the financial condition and results of operations of Atlantic American Corporation (“Atlantic American” or the “Parent”) and its subsidiaries (collectively
with the Parent, the “Company”) as of and for three month period ended March 31, 2021. This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included elsewhere herein, as
well as with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”).
Atlantic American is an insurance holding company whose operations are conducted primarily through its insurance subsidiaries: American Southern Insurance Company and American Safety Insurance
Company (together known as “American Southern”) and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance Company (together known as “Bankers Fidelity”). Each operating company is managed separately, offers different products and
is evaluated on its individual performance.
On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. In March 2020, the impact of COVID-19 and related actions to attempt to control its spread began to
impact our business operations, and we expect that the pandemic, actions that have been or will be taken in response to it and its overall impact on the economy, will continue to have an effect on our business operations and our operating results.
See “Expected Impact of COVID-19 on the Company’s Financial Condition and Results of Operations.”
Critical Accounting Policies
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions
that affect reported amounts and related disclosures. Actual results could differ significantly from those estimates. The Company has identified certain estimates that involve a higher degree of judgment and are subject to a significant degree of
variability. The Company’s critical accounting policies and the resultant estimates considered most significant by management are disclosed in the 2020 Annual Report. Except as disclosed in Note 2 of Notes to Condensed Consolidated Financial
Statements, the Company’s critical accounting policies are consistent with those disclosed in the 2020 Annual Report.
Overall Corporate Results
The following presents the Company’s revenue, expenses and net loss for the three month period ended March 31, 2021 and the comparable period in 2020:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
(In thousands)
|
||||||||
|
Insurance premiums, net
|
$
|
46,090
|
$
|
45,550
|
||||
|
Net investment income
|
2,113
|
2,039
|
||||||
|
Realized investment gains, net
|
121
|
249
|
||||||
|
Unrealized gains (losses) on equity securities, net
|
744
|
(8,455
|
)
|
|||||
|
Other income
|
7
|
27
|
||||||
|
Total revenue
|
49,075
|
39,410
|
||||||
|
Insurance benefits and losses incurred
|
33,272
|
33,583
|
||||||
|
Commissions and underwriting expenses
|
12,564
|
12,626
|
||||||
|
Interest expense
|
346
|
476
|
||||||
|
Other expense
|
3,440
|
2,952
|
||||||
|
Total benefits and expenses
|
49,622
|
49,637
|
||||||
|
Loss before income taxes
|
$
|
(547
|
)
|
$
|
(10,227
|
)
|
||
|
Net Loss
|
$
|
(431
|
)
|
$
|
(8,087
|
)
|
||
Management also considers and evaluates performance by analyzing the non-GAAP measure operating income (loss), and believes it is a useful metric for investors, potential investors, securities
analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of management (such as taxes, which are subject to timing, regulatory and rate changes depending
on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operational results (such as any realized and unrealized investment gains, which are not a part of the Company’s primary operations and
are, to a limited extent, subject to discretion in terms of timing of realization).
A reconciliation of net loss to operating loss for the three month period ended March 31, 2021 and the comparable period in 2020 is as follows:
|
Three Months Ended
March 31,
|
||||||||
|
Reconciliation of Non-GAAP Financial Measure
|
2021
|
2020
|
||||||
|
(In thousands)
|
||||||||
|
Net loss
|
$
|
(431
|
)
|
$
|
(8,087
|
)
|
||
|
Income tax benefit
|
(116
|
)
|
(2,140
|
)
|
||||
|
Realized investment gains, net
|
(121
|
)
|
(249
|
)
|
||||
|
Unrealized (gains) losses on equity securities, net
|
(744
|
)
|
8,455
|
|||||
|
Non-GAAP operating loss
|
$
|
(1,412
|
)
|
$
|
(2,021
|
)
|
||
On a consolidated basis, the Company had net loss of $0.4 million, or $0.03 per diluted share, for the three month period ended March 31, 2021, compared to net loss of $8.1 million, or $0.40 per
diluted share, for the three month period ended March 31, 2020. Premium revenue for the three month period ended March 31, 2021 increased $0.5 million, or 1.2%, to $46.1 million from $45.6 million in the three month period ended March 31, 2020.
The increase in premium revenue was primarily attributable to an increase in the automobile physical damage and automobile liability lines of business in the property and casualty operations. Partially offsetting this increase in premium revenue
was a decrease in the Medicare supplement premiums in the life and health operations.
Operating loss decreased $0.6 million in the three month period ended March 31, 2021 from the three month period ended March 31, 2020. The decrease in operating loss was primarily due to favorable
loss experience in the life and health operations, resulting from improved rate adequacy coupled with a decrease in the number of incurred claims within the Medicare supplement line of business. This decrease in the number of incurred claims was
primarily attributable to the Company’s individual policy holders being subject to varying degrees of shelter in place orders instituted throughout the United States as a result of the COVID-19 pandemic.
A more detailed analysis of the individual operating segments and other corporate activities follows.
American Southern
The following summarizes American Southern’s premiums, losses, expenses and underwriting ratios for the three month period ended March 31, 2021 and the comparable period in 2020:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
(Dollars in thousands)
|
||||||||
|
Gross written premiums
|
$
|
11,462
|
$
|
9,618
|
||||
|
Ceded premiums
|
(1,684
|
)
|
(1,394
|
)
|
||||
|
Net written premiums
|
$
|
9,778
|
$
|
8,224
|
||||
|
Net earned premiums
|
$
|
16,615
|
$
|
14,922
|
||||
|
Insurance benefits and losses incurred
|
11,749
|
9,534
|
||||||
|
Commissions and underwriting expenses
|
4,286
|
4,814
|
||||||
|
Underwriting income
|
$
|
580
|
$
|
574
|
||||
|
Loss ratio
|
70.7
|
%
|
63.9
|
%
|
||||
|
Expense ratio
|
25.8
|
32.3
|
||||||
|
Combined ratio
|
96.5
|
%
|
96.2
|
%
|
||||
Gross written premiums at American Southern increased $1.8 million, or 19.2%, during the three month period ended March 31, 2021 from the comparable period in 2020. The increase in gross written
premiums was primarily attributable to an increase in premiums written in the automobile physical damage line of business from existing agencies, as well as increases in the automobile liability line of business due to retro premium adjustments.
Also contributing to the increase in gross written premiums was an increase in premiums written in the general liability line of business as a result of a new program that started in the second half of 2020.
Ceded premiums increased $0.3 million, or 20.8%, during the three month period ended March 31, 2021 from the comparable period in 2020. American Southern’s ceded premiums are typically determined
as a percentage of earned premiums and generally increase or decrease as earned premiums increase or decrease. Also contributing to the increase in ceded premiums in 2021 was an increase in earned premiums and reinsurance rates in certain accounts
within the automobile physical damage and general liability lines of business, which are subject to reinsurance.
The following presents American Southern’s net earned premiums by line of business for the three month period ended March 31, 2021 and the comparable periods in 2020:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
(In thousands)
|
||||||||
|
Automobile liability
|
$
|
7,737
|
$
|
7,140
|
||||
|
Automobile physical damage
|
5,534
|
4,548
|
||||||
|
General liability
|
1,253
|
851
|
||||||
|
Surety
|
1,317
|
1,605
|
||||||
|
Other lines
|
774
|
778
|
||||||
|
Total
|
$
|
16,615
|
$
|
14,922
|
||||
Net earned premiums increased $1.7 million, or 11.3%, during the three month period ended March 31, 2021 over the comparable period in 2020. The increase in net earned premiums was primarily
attributable to an increase in automobile physical damage coverage resulting from existing agencies as previously mentioned, as well as premium adjustments on a large automobile liability account. Premiums are earned ratably over their respective
policy terms, and therefore premiums earned in the current year are related to policies written during both the current year and immediately preceding year.
The performance of an insurance company is often measured by its combined ratio. The combined ratio represents the percentage of losses, loss adjustment expenses and other expenses that are
incurred for each dollar of premium earned by the company. A combined ratio of under 100% represents an underwriting profit while a combined ratio of over 100% indicates an underwriting loss. The combined ratio is divided into two components, the
loss ratio (the ratio of losses and loss adjustment expenses incurred to premiums earned) and the expense ratio (the ratio of expenses incurred to premiums earned).
Insurance benefits and losses incurred at American Southern increased $2.2 million, or 23.2%, during the three month period ended March 31, 2021 over the comparable period in 2020. As a percentage
of earned premiums, insurance benefits and losses incurred were 70.7% in the three month period ended March 31, 2021, compared to 63.9% in the three month period ended March 31, 2020. The increase in the loss ratio during the three month period
ended March 31, 2021 was primarily due to an increase in the frequency of claims in the automobile physical damage line of business, as well as in the inland marine segment of the other line of business.
Commissions and underwriting expenses decreased $0.5 million, or 11.0%, during the three month period ended March 31, 2021, over the comparable period in 2020. As a percentage of earned premiums,
underwriting expenses were 25.8% in the three month period ended March 31, 2021, compared to 32.3% in the three month period ended March 31, 2020. The decrease in the expense ratio during the three month period ended March 31, 2021 was primarily
due to American Southern’s use of a variable commission structure with certain agents, which compensates the participating agents in relation to the loss ratios of the business they write. During periods in which the loss ratio decreases,
commissions and underwriting expenses will generally increase, and conversely, during periods in which the loss ratio increases, commissions and underwriting expenses will generally decrease. During the three month period ended March 31, 2021,
variable commissions at American Southern decreased by $0.4 million, respectively, from the comparable periods in 2020 due to less favorable loss experience from accounts subject to variable commissions.
Bankers Fidelity
The following summarizes Bankers Fidelity’s earned premiums, losses, expenses and underwriting ratios for the three month period ended March 31, 2021 and the comparable period in 2020:
|
Three Months Ended
March 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
(Dollars in thousands)
|
||||||||
|
Medicare supplement
|
$
|
40,992
|
$
|
44,315
|
||||
|
Other health products
|
2,387
|
2,184
|
||||||
|
Life insurance
|
2,887
|
2,257
|
||||||
|
Gross earned premiums
|
46,266
|
48,756
|
||||||
|
Ceded premiums
|
(16,791
|
)
|
(18,128
|
)
|
||||
|
Net earned premiums
|
29,475
|
30,628
|
||||||
|
Insurance benefits and losses incurred
|
21,523
|
24,049
|
||||||
|
Commissions and underwriting expenses
|
9,885
|
9,604
|
||||||
|
Total expenses
|
31,408
|
33,653
|
||||||
|
Underwriting loss
|
$
|
(1,933
|
)
|
$
|
(3,025
|
)
|
||
|
Loss ratio
|
73.0
|
%
|
78.5
|
%
|
||||
|
Expense ratio
|
33.5
|
31.4
|
||||||
|
Combined ratio
|
106.5
|
%
|
109.9
|
%
|
||||
Net earned premium revenue at Bankers Fidelity decreased $1.2 million, or 3.8%, during the three month period ended March 31, 2021, from the comparable period in 2020. Gross earned premiums from
the Medicare supplement line of business decreased $3.3 million, or 7.5%, during the three month period ended March 31, 2021, due primarily to non-renewals exceeding the level of new business writings. Other health product premiums increased $0.2
million, or 9.3%, during the three month period ended March 31, 2021, over the comparable period in 2020, primarily as a result of new sales of the company’s group health products. Gross earned premiums from the life insurance line of business
increased $0.6 million, or 27.9%, during the three month period ended March 31, 2021 over the comparable period in 2020 due to an increase in the group life products premium. Partially offsetting the increase in gross earned premiums from the life
insurance line was a decrease in individual life products premium, resulting from the redemption and settlement of existing individual life policy obligations exceeding the level of new individual life sales. Premiums ceded decreased $1.3 million,
or 7.4%, during the three month period ended March 31, 2021, from the comparable period in 2020. The decrease in ceded premiums for the three month period ended March 31, 2021 was due to a decrease in Medicare supplement premiums subject to
reinsurance.
Insurance benefits and losses incurred decreased $2.5 million, or 10.5%, during the three month period ended March 31, 2021, from the comparable period in 2020. As a percentage of earned premiums,
insurance benefits and losses incurred were 73.0% in the three month period ended March 31, 2021, compared to 78.5% in the three month period ended March 31, 2020. The decrease in the loss ratio for the three month period ended March 31, 2021 was
primarily due to improved rate adequacy coupled with a decrease in the number of incurred claims within the Medicare supplement line of business. This decrease in the number of incurred claims was primarily attributable to the Company’s individual
policy holders being subject to varying degrees of shelter in place orders instituted throughout the United States as a result of the COVID-19 pandemic.
Commissions and underwriting expenses increased $0.3 million, or 2.9%, during the three month period ended March 31, 2021, over the comparable period in 2020. As a percentage of earned premiums,
underwriting expenses were 33.5% in the three month period ended March 31, 2021, compared to 31.4% in the three month period ended March 31, 2020. The increase in the expense ratio for the three month period ended March 31, 2021 was primarily due
to the amortization of deferred acquisition costs (“DAC”) exceeding the level of additions to DAC. The increase in the net amortization of DAC during 2021 is primarily due to non-renewals exceeding the level of new business writings in the Medicare
supplement line of business, as previously mentioned. Partially offsetting the increase in the expense ratio was a decrease in expenses related to servicing the Medicare supplement line of business.
Net Investment Income and Realized Gains
Investment income increased $0.1 million, or 3.6%, during the three month period ended March 31, 2021, from the comparable period in 2020. The increase in investment income was attributable to an
increase in the equity in earnings from investments in the Company’s limited partnerships and limited liability companies of $0.1 million.
The Company had net realized investment gains of $0.1 million during the three month period ended March 31, 2021, compared to net realized investment gains of $0.2 million during the three month
period ended March 31, 2020. The net realized investment gains during the three month periods ended March 31, 2021 and March 31, 2020 resulted primarily from the disposition of several of the Company’s investments in fixed maturities. Management
continually evaluates the Company’s investment portfolio and makes adjustments for impairments and/or divests investments as may be determined to be appropriate.
Unrealized Gains (Losses) on Equity Securities
Investments in equity securities are measured at fair value at the end of the reporting period, with any changes in fair value reported in net income during the period. The Company recognized net
unrealized gains on equity securities of $0.7 million during the three month period ended March 31, 2021 and unrealized losses on equity securities of $8.5 million during the three month period ended March 31, 2020. Changes in unrealized gains on
equity securities for the applicable periods are primarily the result of fluctuations in the market value of certain of the Company’s equity securities.
Interest Expense
Interest expense decreased $0.1 million, or 27.3%, during the three month period ended March 31, 2021, from the comparable period in 2020. Changes in interest expense were primarily due to changes
in the London Interbank Offered Rate (“LIBOR”), as the interest rates on the Company’s outstanding junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) are directly related to LIBOR.
Liquidity and Capital Resources
The primary cash needs of the Company are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements. Current
and expected patterns of claim frequency and severity may change from period to period but generally are expected to continue within historical ranges. The Company’s primary sources of cash are written premiums, investment income and proceeds from
the sale and maturity of its invested assets. The Company believes that, within each operating company, total invested assets will be sufficient to satisfy all policy liabilities and that cash inflows from investment earnings, future premium
receipts and reinsurance collections will be adequate to fund the payment of claims and operating expenses as needed.
Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments, as described below, from the subsidiaries. The principal cash needs of the Parent are for the payment
of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company’s board of directors from time to time. At
March 31, 2021, the Parent had approximately $3.8 million of unrestricted cash and investments.
The Parent’s insurance subsidiaries reported statutory net income of $2.1 million for the three month period ended March 31, 2021, compared to statutory net income of $0.2 million for the three
month period ended March 31, 2020. Statutory results are impacted by the recognition of all costs of acquiring business. In periods in which the Company’s first year premiums increase, statutory results are generally lower than results determined
under GAAP. Statutory results for the Company’s property and casualty operations may differ from the Company’s results of operations under GAAP due to the deferral of acquisition costs for financial reporting purposes. The Company’s life and health
operations’ statutory results may differ from GAAP results primarily due to the deferral of acquisition costs for financial reporting purposes, as well as the use of different reserving methods.
Over 90% of the invested assets of the Parent’s insurance subsidiaries are invested in marketable securities that can be converted into cash, if required; however, the use of such assets by the
Company is limited by state insurance regulations. Dividend payments to a parent corporation by its wholly owned insurance subsidiaries are subject to annual limitations and are restricted to 10% of statutory surplus or statutory earnings before
recognizing realized investment gains of the individual insurance subsidiaries. At March 31, 2021, American Southern had $49.3 million of statutory capital and surplus and Bankers Fidelity had $42.1 million of statutory capital and surplus. In
2021, dividend payments by the Parent’s insurance subsidiaries in excess of $9.6 million would require prior approval. Through March 31, 2021, the Parent received dividends of $3.9 million from its subsidiaries.
The Parent provides certain administrative and other services to each of its insurance subsidiaries. The amounts charged to and paid by the subsidiaries include reimbursements for various shared
services and other expenses incurred directly on behalf of the subsidiaries by the Parent. In addition, there is in place a formal tax-sharing agreement between the Parent and its insurance subsidiaries. As a result of the Parent’s tax loss, it is
anticipated that the tax-sharing agreement will continue to provide the Parent with additional funds from profitable subsidiaries to assist in meeting its cash flow obligations.
The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and
investing the gross proceeds of the trust preferred securities in Junior Subordinated Debentures. The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are
callable quarterly, in whole or in part, only at the option of the Company, and have an interest rate of three-month LIBOR plus an applicable margin. The margin ranges from 4.00% to 4.10%. At March 31, 2021, the effective interest rate was 4.25%.
The obligations of the Company with respect to the issuances of the trust preferred securities represent a full and unconditional guarantee by the Parent of each trust’s obligations with respect to the trust preferred securities. Subject to certain
exceptions and limitations, the Company may elect from time to time to defer Junior Subordinated Debenture interest payments, which would result in a deferral of distribution payments on the related trust preferred securities. As of March 31, 2021,
the Company has not made such an election.
The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from
potential future financing arrangements.
At March 31, 2021, the Company had 55,000 shares of Series D preferred stock (“Series D Preferred Stock”) outstanding. All of the shares of Series D Preferred Stock are held by an affiliate of the
Company’s controlling shareholder. The outstanding shares of Series D Preferred Stock have a stated value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company’s common stock at the option
of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company’s common stock, subject to
certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company’s option.
The Series D Preferred Stock is not currently convertible. At March 31, 2021, the Company had accrued but unpaid dividends on the Series D Preferred Stock totaling $0.1 million.
Bankers Fidelity Life Insurance Company (‘‘BFLIC’) is a member of the Federal Home Loan Bank of Atlanta (“FHLB”), for the primary purpose of enhancing financial flexibility. As a member, BFLIC can obtain access to
low-cost funding and also receive dividends on FHLB stock. The membership arrangement established initial credit availability of five percent of statutory admitted assets, or approximately $8 million. Additional FHLB stock purchases may be required
based upon the amount of funds borrowed from the FHLB. BFLIC would be required to post acceptable forms of collateral for any borrowings it makes from the FHLB. To date, BFLIC has not made any borrowings from the FHLB.
Cash and cash equivalents increased from $19.3 million at December 31, 2020 to $20.4 million at March 31, 2021. The increase in cash and cash equivalents during the three month period ended
March 31, 2021 was primarily attributable to net cash provided by investing activities of $7.2 million as a result of investment sales and maturity of securities exceeding investment purchases. Largely offsetting the net cash provided by
investing activities was $6.0 million in net cash used in operating activities.
The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, additional borrowings from
financial institutions, will enable the Company to meet its liquidity requirements for the foreseeable future. Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse
effect on the Company’s liquidity, capital resources or operations.
Expected Impact of COVID-19 on the Company’s Financial Condition and Results of Operations
The duration and ultimate impact of the COVID-19 pandemic remains unknown at this time and it is not possible for us to reliably estimate the impact on the financial condition, operating results or
liquidity of the Company and its operating subsidiaries in future periods. However, we do not currently expect a significant decline in liquidity or operating results as a result of the disruption caused by the ongoing COVID-19 pandemic. To date,
the most significant impact of COVID-19 on the Company’s financial position has been volatility in the fair value of the Company’s fixed maturity and equity investments due to disruption in the financial markets.
We expect that earned premiums could be adversely impacted by a weakened economy leading to a slowdown in new sales and reduced retention of insureds. Additionally, a number of states have issued
bulletins that either encourage or require premium leniency such as extension of grace periods or moratoriums on cancellation of policies for non-payment. The Company does not expect a significant reduction or delay in payments and continues to
monitor state required actions as they develop.
For the Company’s property and casualty operations, the majority of premium revenue is derived from automobile liability and automobile physical damage lines of business written on a multi-year contract basis with
state and local governments. Although we cannot predict with certainty at this time, we do not expect a significant level of cancellations or non-renewals of our property and casualty contracts in the short term but recognize that a prolonged
economic slowdown could adversely affect future results. However, the Company expects the aforementioned decline in usage to be temporary in nature.
Benefits and losses in our property and casualty operations could be adversely impacted as a result of disruption caused by the COVID-19 pandemic. However, due to the nature of our primary product
lines, the impact is not currently expected to be material. As a result, we do not currently expect a material adverse effect on operating results or liquidity in the property and casualty operations.
The majority of premium revenue in our life and health operations are derived from the senior market segment of the population, or those individuals age sixty-five and up, who maintain Medicare
supplement and to a lesser extent, whole life insurance policies with the Company. We expect that earned premiums could be adversely impacted by an economic slowdown related to the COVID-19 pandemic and individual, business and government
responses thereto, which could lead to a decline in new sales and reduced retention of insureds. As a result, we currently anticipate that the life and health operations may experience a marginal decline in earned premiums although the actual
impact cannot be predicted with certainty at this time.
Unforeseen infectious diseases that impact large portions of a population can have an adverse impact on mortality and morbidity, and resultant benefits and losses incurred by the Company’s life and
health operations. Accordingly, the Company does anticipate incurring higher costs, potentially similar to prior influenza seasons, as it relates to life insurance claims. However, due to the Company’s individual policyholders being subject to
various degrees of shelter in place orders, the Company has experienced lower utilization of certain accident and health benefits, particularly in the Medicare supplement line of business. As a result, and although the ultimate impact cannot be
predicted with certainty at this time, the Company does not expect significant adverse development in total benefits and losses incurred in its life and health operations.
In addition to the information set forth in this report, you should carefully consider the discussions of the COVID-19 pandemic and related economic developments presented in our Annual Report on
Form 10-K for the year ended December 31, 2020, and in other reports we file with the SEC from time to time, all of which could materially affect our business, financial condition or future results.
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act of 1934 (the “Exchange Act”) reports is recorded,
processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and
Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management necessarily applies its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide
only reasonable assurance regarding management’s control objectives. The Company’s management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures can prevent all possible
errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. There are inherent limitations in all control systems, including
the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the intentional acts of one or more persons. The design of any system
of controls is based in part upon certain assumptions about the likelihood of future events, and, while our disclosure controls and procedures are designed to be effective under circumstances where they should reasonably be expected to operate
effectively, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in any control system, misstatements due to possible errors or fraud may
occur and may not be detected. An evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of
our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our management, including the Chief Executive Officer and Chief
Financial Officer, concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
There have been no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains and references certain information that constitutes forward-looking statements as that term is defined in the federal securities laws. Statements, to the
extent they are not statements of historical facts, are considered forward-looking statements, and are subject to various risks and uncertainties. Such forward-looking statements are made based upon management’s current assessments of various risks
and uncertainties, as well as assumptions made in accordance with the “safe harbor” provisions of the federal securities laws. The Company’s actual results could differ materially from the results expressed in or implied by these forward-looking
statements as a result of such risks and uncertainties, including those identified in filings made by the Company from time to time with the Securities and Exchange Commission. In addition, other risks and uncertainties not known by us, or that we
currently determine to not be material, may materially adversely affect our financial condition, results of operations or cash flows. The Company undertakes no obligation to update any forward-looking statement as a result of subsequent
developments, changes in underlying assumptions or facts, or otherwise, except as may be required by law.
PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On October 31, 2016, the Board of Directors of the Company approved a plan that allows for the repurchase of up to 750,000 shares of the Company’s common stock (the “Repurchase Plan”) on the open
market or in privately negotiated transactions, as determined by an authorized officer of the Company. Any such repurchases can be made from time to time in accordance with applicable securities laws and other requirements.
Other than pursuant to the Repurchase Plan, no purchases of common stock of the Company were made by or on behalf of the Company during the periods described below.
The table below sets forth information regarding repurchases by the Company of shares of its common stock on a monthly basis during the three month period ended March 31, 2021.
|
Period
|
Total Number
of Shares
Purchased
|
Average
Price Paid
per Share
|
Total Number of
Shares Purchased
as Part of
Publicly
Announced Plans
or Programs
|
Maximum Number
of Shares that
May Yet be
Purchased
Under the Plans
or Programs
|
||||||||||||
|
January 1 – January 31, 2021
|
—
|
$
|
—
|
—
|
325,129
|
|||||||||||
|
February 1 – February 28, 2021
|
—
|
—
|
—
|
325,129
|
||||||||||||
|
March 1 –March 31, 2021
|
—
|
—
|
—
|
325,129
|
||||||||||||
|
Total
|
—
|
$
|
—
|
—
|
||||||||||||
Item 6. Exhibits
|
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101. INS
|
XBRL Instance Document.
|
|
101. SCH
|
XBRL Taxonomy Extension Schema.
|
|
101. CAL
|
XBRL Taxonomy Extension Calculation Linkbase.
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase.
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase.
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
ATLANTIC AMERICAN CORPORATION
|
|||
|
(Registrant)
|
|||
|
Date: May 11, 2021
|
By:
|
/s/ J. Ross Franklin
|
|
|
J. Ross Franklin
|
|||
|
Vice President and Chief Financial Officer
|
|||
|
(Principal Financial and Accounting Officer)
|
|||
23
EXHIBIT 31.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Hilton H. Howell, Jr., certify that:
| 1. |
I have reviewed this report on Form 10-Q of Atlantic American Corporation;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| a) |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| b) |
designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;
|
| c) |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and
|
| d) |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth
fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
| 5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the
audit committee of registrant’s board of directors (or persons performing the equivalent functions):
|
| a) |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the
registrant’s ability to record, process, summarize and report financial information; and
|
| b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
Date: May 11, 2021
|
/s/ Hilton H. Howell, Jr.
|
|
|
Hilton H. Howell, Jr.
|
||
|
President and Chief Executive Officer
|
EXHIBIT 31.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, J. Ross Franklin, certify that:
| 1. |
I have reviewed this report on Form 10-Q of Atlantic American Corporation;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| a) |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| b) |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
| c) |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
|
| d) |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
| 5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors
(or persons performing the equivalent functions):
|
| a) |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
|
| b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
Date: May 11, 2021
|
/s/ J. Ross Franklin
|
|
|
J. Ross Franklin
|
||
|
Vice President and Chief Financial Officer
|
EXHIBIT 32.1
Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly Report on Form 10-Q of Atlantic American
Corporation (the “Company”) for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, that, to such officer’s
knowledge:
| (1) |
The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
|
| (2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
|
|
Date: May 11, 2021
|
/s/ Hilton H. Howell, Jr.
|
|
|
Hilton H. Howell, Jr.
|
||
|
President and Chief Executive Officer
|
||
|
Date: May 11, 2021
|
/s/ J. Ross Franklin
|
|
|
J. Ross Franklin
|
||
|
Vice President and Chief Financial Officer
|
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the
electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.